1015-P: Acceptability and Impact of a Spanish-Language Diabetes Management Smartphone Application (mySugr PRO) in Hispanic/Latino Adults with Uncontrolled Type 2 Diabetes

Hispanic/Latino (H/L) adults are disproportionately affected and have suboptimal control of Type 2 Diabetes (T2DM). We hypothesize that use of a Spanish-language smartphone application with structured blood glucose (BG) monitoring and proactive diabetes coaching (mySugr® PRO) will improve diabetes self-efficacy, weight, and glucose control in H/L adults with uncontrolled T2DM. Spanish-literate H/L adults with non-intensively treated T2DM and HbA1c 7.5-10.0% were enrolled. Subjects were provided with an Accu-Chek® Guide Me glucometer, trained on use of mySugr® PRO, received education on structured BG monitoring (paired testing before and 2hr post-meal), and given access to diabetes coaching. BG metrics, HbA1c, weight, waist circumference, diabetes self-efficacy and distress were measured before and after 12-weeks; acceptability Abbott, Dexcom, Inc. Speaker's Bureau; Dexcom, Inc. Research Support; Lilly Diabetes, Medtronic, MannKind Corporation, Insulet Corporation. Consultant; Medscape. D. Kerr: Advisory Panel; Abbott Diagnostics. Consultant; Sanofi, Better Therapeutics, Inc. Stock/Shareholder; Glooko, Inc. B. Ulmer: Employee; Roche Diabetes Care. E. Repetto: Employee; Roche Diabetes Care. K. Gonzalez: None. L. Melero: None.